A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Pelz, Joerg O W ^a   Doerfer, Joerg ^a   Hohenberger, Werner ^a   Meyer, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MITOMYCIN C; MITOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPSY; CANCER TRANSPLANTATION; CARCINOMA CELL; CARCINOMATOUS PERITONITIS; COLON CARCINOMA; CONCENTRATION RESPONSE; CONJUNCTIVITIS; CONTROLLED STUDY; DEATH; DRUG DOSE REGIMEN; EXPERIMENTAL MODEL; HYPERTHERMIA; HYPERTHERMIC THERAPY; LETHARGY; MALE; MONOTHERAPY; NONHUMAN; POSTOPERATIVE PERIOD; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TISSUE PERFUSION; TUMOR CLASSIFICATION; TUMOR GROWTH; ANIMAL; BODY WEIGHT; DOSE RESPONSE; EXPERIMENTAL NEOPLASM; INFUSION; LIVER TUMOR; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PERFUSION; PERITONEUM TUMOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; BODY WEIGHT; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; LIVER NEOPLASMS; MITOMYCIN; MODELS, STATISTICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PERFUSION; PERITONEAL NEOPLASMS; RATS; TIME FACTORS; TREATMENT OUTCOME;

EID: 26844538050     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-56     Document Type: Article

References (18)

1. Minsky BD, Mies C, Rich T.A, Recht A, Chaffey JT: Potentially curative surgery of colon cancer: patterns of failure and survival. J. Clin. Oncol. 6; 106-118.
2. Verwaal VJ, van Ruth S, de Bree E, van Slooten G, van Tinteren H, Boot H, Zoetmulder F.A.N: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 12: 3737-3743
3. Los G, Mutsaers PH, van der Vijgh WJ, Baldew GS, de Graaf PW, McVie JG: Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res. 1989 Jun 15; 49:3380-4.
4. Los G, Sminia P, Wondergem J, Mutsaers PH, Havemen J, ten Bokkel Huinink D, Smals O, Gonzalez-Gonzalez D, McVie JG: Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer. 1991; 27:472-7.
5. Fernandez-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH: Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. Cancer Treat Res. 1996; 81:51-61.
6. Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW: Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer. 2001 May; 37:979-84.
7. Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M: Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 1967 Sep; 20:1351-81.
8. Isacoff WH, Borud K: Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview. World J Surg. 1997 Sep;21:748-62.
9. Marquet RC, Westbroek DL, Jeekel J: Interferon treatment of a transplantable colon adenocarcinoma, importance of tumor site. Br J Cancer 1984;33:698-692.
10. Steller EP, Ottow RT, Matthews W, Sugarbaker PH, Rosenberg SH: Recombinan tinterleukin-2 andadoptively transferred lymphokine-activated killer cells in the treatment of experimental peritoneal carcinomatosis. Surg Forum 1985; 36: 390-2
11. Spratt JS, Adcock RA, Muskovin M, Sherrilll W, McKeown J: Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980; 40:256-60
12. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004 Aug 15;22:3284-92.
13. Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004 Aug;240(2):278-85.
14. van Ruth S, Verwaal VJ, Hart AA, van Slooten GW, Zoetmulder FA: Heat penetration in locally applied hyperthermia in the abdomen during intrapostoperative hyperthermic intraperitoneal chemotherapy. Anticancer Res. 2003;23:1501-8
15. Veenhuizen RB, Marijnissen JP, Kenemans P, Ruevekamp-Helmers MC, 't Mannetje LW, Helmerhorst TJ, Stewart FA: Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma. Br J Cancer. 1996;73(11):1387-92
16. Storm FK: Clinical hyperthermia and chemotherapy. Radiol. Clin. N. America 1989; 27: 621-627
17. Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FAN: Toxicity of Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy. J Surg Oncol. 2004; 85:61-67
18. Hribaschek A, Kuhn R, Pross M, Lippert H, Halangk W, Boltze, C, Ridwelski K: Prophylaxis of peritoneal carcinomatosis in experimental investigations. Int J Colorectal Dis 2001; 16 :340-345